{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:42:55Z","timestamp":1762864975760},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1986,4,1]],"date-time":"1986-04-01T00:00:00Z","timestamp":512697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J, Clin. Microbiol."],"published-print":{"date-parts":[[1986,4]]},"DOI":"10.1007\/bf02013993","type":"journal-article","created":{"date-parts":[[2005,8,11]],"date-time":"2005-08-11T20:02:19Z","timestamp":1123790539000},"page":"214-219","source":"Crossref","is-referenced-by-count":31,"title":["Overview of clinical experience with ciprofloxacin"],"prefix":"10.1007","volume":"5","author":[{"given":"A. P.","family":"Ball","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02013993_CR1","first-page":"4","volume":"2","author":"A. P. Ball","year":"1985","unstructured":"Ball, A. P., Reeves, D. S.: Clinical experience with piperazinyl substituted 4-quinolones. Quinolones Bulletin 1985, 2: 4\u20135.","journal-title":"Quinolones Bulletin"},{"key":"BF02013993_CR2","unstructured":"Smith, J. T.: Awakening the slumbering potential of the 4-quinolone antibacterials. Pharmaceutical Journal 1984, 229\u2013305."},{"key":"BF02013993_CR3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jac\/13.4.333","volume":"13","author":"D. S. Reeves","year":"1984","unstructured":"Reeves, D. S., Bywater, M. J., Holt, H. A., White, L. O.: In vitro studies with ciprofloxacin, a new 4-quinolone compound. Journal of Antimicrobial Chemotherapy 1984, 13: 333\u2013346.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"Supplement C","key":"BF02013993_CR4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/14.suppl_C.7","volume":"14","author":"D. S. Reeves","year":"1984","unstructured":"Reeves, D. S., Bywater, M. J., Holt, H. A.: The activity of enoxacin against clinical bacterial isolates in comparison with that of five other agents, and factors affecting that activity. Journal of Antimicrobial Chemotherapy 1984, 14 Supplement C: 7\u201317.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02013993_CR5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jac\/15.1.39","volume":"15","author":"A. M. Clarke","year":"1985","unstructured":"Clarke, A. M., Zemcov, S. J. V., Campbell, M. E.: In vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams. Journal of Antimicrobial Chemotherapy 1985, 15: 39\u201344.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02013993_CR6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000238309","volume":"31","author":"W. Cullmann","year":"1985","unstructured":"Cullmann, W., Stieglitz, M., Baars, B., Opferkuch, W.: Comparative evaluation of recently developed quinolone compounds \u2014 with a note on the frequency of resistant mutants. Chemotherapy 1985, 31: 19\u201328.","journal-title":"Chemotherapy"},{"key":"BF02013993_CR7","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/AAC.24.4.568","volume":"24","author":"R. J. Fass","year":"1983","unstructured":"Fass, R. J.: In vitro activity of ciprofloxacin (Bay 09867). Antimicrobial Agents and Chemotherapy 1983, 24: 568\u2013574.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02013993_CR8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jac\/13.4.325","volume":"13","author":"A. King","year":"1984","unstructured":"King, A., Shannon, K., Phillips, I.: The in vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid. Journal of Antimicrobial Chemotherapy 1984, 13: 325\u2013331.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02013993_CR9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1128\/AAC.23.4.559","volume":"23","author":"R. Wise","year":"1983","unstructured":"Wise, R., Andrews, J. M., Bedford, L. J.: In vitro activity of Bay 09867, a new quinolone derivative, compared with those of other antimicrobial agents. Antimicrobial Agents and Chemotherapy 1983, 23: 559\u2013564.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02013993_CR10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0140-6736(83)90257-X","volume":"i","author":"D. Greenwood","year":"1983","unstructured":"Greenwood, D., Laverick, A.: Activities of newer quinolones against legionella group organisms. Lancet 1983, i: 279\u2013280.","journal-title":"Lancet"},{"key":"BF02013993_CR11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1128\/AAC.25.3.319","volume":"25","author":"N.-X. Chin","year":"1984","unstructured":"Chin, N.-X., Neu, H. C.: Ciprofloxacin: a quinolone-carboxylic acid active against aerobic and anaerobic bacteria. Antimicrobial Agents and Chemotherapy 1984, 25: 319\u2013326.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02013993_CR12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/BF01977491","volume":"3","author":"G. L. Ridgway","year":"1984","unstructured":"Ridgway, G. L., Mumtaz, G., Gabriel, F. G., Oriel, J. D.: The activity of ciprofloxacin and other 4-quinolones againstChlamydia trachomatis and mycoplasmas in vitro. European Journal of Clinical Microbiology 1984, 3: 344\u2013346.","journal-title":"European Journal of Clinical Microbiology"},{"key":"BF02013993_CR13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1128\/AAC.27.3.375","volume":"27","author":"G. Hoffken","year":"1985","unstructured":"Hoffken, G., Lode, H., Prinzing, C., Borner, K., Koeppe, P.: Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrobial Agents and Chemotherapy 1985, 27: 375\u2013379.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02013993_CR14","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1128\/AAC.27.3.350","volume":"27","author":"B. Ledergerber","year":"1985","unstructured":"Ledergerber, B., Bettex, J-D., Joos, B., Flepp, M., Luthy, R.: Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin. Antimicrobial Agents and Chemotherapy 1985, 27: 350\u2013352.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02013993_CR15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF02013667","volume":"4","author":"G. Hoffken","year":"1985","unstructured":"Hoffken, G., Borner, K., Glatzel, P. D., Koeppe, P., Lode, H.: Reduced enteral absorption of ciprofloxacin in the presence of antacids. European Journal of Clinical Microbiology 1985, 4: 345.","journal-title":"European Journal of Clinical Microbiology"},{"key":"BF02013993_CR16","first-page":"23","volume-title":"Ciprofloxacin: a new 4-quinolone","author":"T. Bergan","year":"1985","unstructured":"Bergan, T., Dalhoff, A., Thorsteinsson, S. B.: A review of the pharmacokinetics and tissue penetration of ciprofloxacin. In: Ciprofloxacin: a new 4-quinolone. Sieber and McIntyre Inc. Hongkong, 1985, p. 23\u201336."},{"key":"BF02013993_CR17","doi-asserted-by":"crossref","unstructured":"Ball, A. P., Fox, C., Ball, M. E., Brown, I. R. F., Willis, J. V.: Pharmacokinetics of oral ciprofloxacin, 100 mg single dose, in volunteers and elderly patients. Journal of Antimicrobial Chemotherapy 1986, 17.","DOI":"10.1093\/jac\/17.5.629"},{"key":"BF02013993_CR18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1128\/AAC.27.3.353","volume":"27","author":"B. Joos","year":"1985","unstructured":"Joos, B., Ledergerber, B., Flepp, M., Bettex, J-D., Luthy, R., Siegenthaler, W.: Comparison of high-pressure liquid Chromatography and bioassay for determination of ciprofloxacin in serum and urine. Antimicrobial Agents and Chemotherapy 1985, 27: 353\u2013356.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02013993_CR19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/jac\/16.1.87","volume":"16","author":"J. Boelaert","year":"1985","unstructured":"Boelaert, J., Valcke, Y., Schurgers, M., Daneels, R., Rosseneu, M., Rosseel, M. T., Bogaert, M. G.: The pharmacokinetics of ciproflxoacin in patients with impaired renal function. Journal of Antimicrobial Chemotherapy 1985, 16: 87\u201393.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02013993_CR20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000238308","volume":"31","author":"J. B. J. Boerema","year":"1985","unstructured":"Boerema, J. B. J., Dalhoff, A., Debruyne, F. M. Y.: Ciprofloxacin distribution in prostatic tissue and fluid after oral administration. Chemotherapy 1985, 31: 13\u201318.","journal-title":"Chemotherapy"},{"key":"BF02013993_CR21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1128\/AAC.28.2.311","volume":"28","author":"J.-M. Brogard","year":"1985","unstructured":"Brogard, J.-M., Jehl, F., Monteil, H., Adloff, M., Blickle, J.-F., Levy, P.: Comparison of high-pressure liquid chromatography and microbiological assay for the determination of biliary elimination of ciprofloxacin in humans. Antimicrobial Agents and Chemotherapy 1985, 28: 311\u2013314.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02013993_CR22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000238383","volume":"32","author":"E. Goormans","year":"1986","unstructured":"Goormans, E., Dalhoff, A., Kazzaz, B., Branolte, J.: Penetration of ciprofloxacin into gynaecological tissues following oral and intravenous administration. Chemotherapy 1986, 32: 7\u201317.","journal-title":"Chemotherapy"},{"key":"BF02013993_CR23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF02013986","volume":"5","author":"E. Bergogne-Berezin","year":"1986","unstructured":"Bergogne-Berezin, E., Berthelot, G., Even, P., Stern, M., Reynaud, P.: Penetration of ciprofloxacin into bronchial secretions. European Journal of Clinical microbiology 1986, 5: 197\u2013200.","journal-title":"European Journal of Clinical microbiology"},{"key":"BF02013993_CR24","first-page":"63","volume":"7","author":"R. Wise","year":"1985","unstructured":"Wise, R., Lockley, M. R., Crump, B., Adhami, Z. N.: The pharmacokinetics and tissue penetration of orally administered enoxacin, norfloxacin and ciprofloxacin. Research and Clinical Forums 1985, 7: 63\u201368.","journal-title":"Research and Clinical Forums"},{"key":"BF02013993_CR25","first-page":"1175","volume":"34","author":"H. Giamarellou","year":"1984","unstructured":"Giamarellou, H., Efstratiou, A., Tsagarakis, J., Petrikkos, G., Daikos, G. K.: Experience with ciprofloxacin in vitro and in vivo. Arzneimittel-Forschung 1984, 34: 1175\u20131178.","journal-title":"Arzneimittel-Forschung"},{"key":"BF02013993_CR26","first-page":"351","volume":"11","author":"H. Giamarellou","year":"1985","unstructured":"Giamarellou, H., Daphnis, E., Dendrinos, C., Daikos, G. K.: Experience with ciprofloxacin in the treatment of various infections caused mainly byPseudomonas aeruginosa. Drugs under Experimental and Clinical Research 1985, 11: 351\u2013356.","journal-title":"Drugs under Experimental and Clinical Research"},{"key":"BF02013993_CR27","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF02014001","volume":"5","author":"S. Mehtar","year":"1986","unstructured":"Mehtar, S., Drabu, Y., Blakemore, P.: Ciprofloxacin in the treatment of infections caused by gentamicin-resistant gram-negative bacteria. European Journal of Clinical Microbiology 1986, 5: 248\u2013251.","journal-title":"European Journal of Clinical Microbiology"},{"key":"BF02013993_CR28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000238392","volume":"32","author":"H. Poppel Van","year":"1986","unstructured":"Van Poppel, H., Wegge, M., Dammekens, H., Chysky, V.: Oral treatment of pseudomonas-induced urinary tract infections with ciprofloxacin. Chemotherapy 1986, 32: 83\u201387.","journal-title":"Chemotherapy"},{"key":"BF02013993_CR29","first-page":"749","volume":"3\u20135","author":"K. Naber","year":"1984","unstructured":"Naber, K., Bartosik-Wich, B.: Therapie komplizierter Harnwegsinfektionen mit norfloxacin versus ciprofloxacin. Fortschritte der antimikrobiellen und antineoplastischen Chemotherapie 1984, 3\u20135: 749\u2013758.","journal-title":"Fortschritte der antimikrobiellen und antineoplastischen Chemotherapie"},{"key":"BF02013993_CR30","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/BF02013999","volume":"5","author":"M. J. A. M. Tegelberg-Stassen","year":"1986","unstructured":"Tegelberg-Stassen, M. J. A. M., van der Hoek, J. C. S., Mooi, L., Wagenvoort, J. H. T., van Joost, T., Michel, M. F., Stolz, E.: Treatment of uncomplicated gonococcal urethritis in men with two dosages of ciprofloxacin. European Journal of Clinical Microbiology 1986, 5: 244\u2013246.","journal-title":"European Journal of Clinical Microbiology"},{"key":"BF02013993_CR31","first-page":"302","volume":"61","author":"P. S. Loo","year":"1985","unstructured":"Loo, P. S., Ridgway, G. L., Oriel, J. D.: Single dose ciprofloxacin for treating gonococcal infections in men. Genitourinary Medicine 1985, 61: 302\u2013305.","journal-title":"Genitourinary Medicine"},{"key":"BF02013993_CR32","first-page":"47","volume-title":"Ciprofloxacin: a new 4-quinolone","author":"K. Yamaguchi","year":"1985","unstructured":"Yamaguchi, K., Hara, K.: Clinical evaluation of Bay 09867 in the field of internal medicine in Japan. In: Ciprofloxacin: a new 4-quinolone. Sieber and McIntyre, Hongkong, 1985, 47\u201353."},{"key":"BF02013993_CR33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/BF02013995","volume":"5","author":"B. I. Davies","year":"1986","unstructured":"Davies, B. I., Maesen, F. P. V., Baur, C.: Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis. European Journal of Clinical Microbiology 1986, 5: 226\u2013231.","journal-title":"European Journal of Clinical Microbiology"},{"key":"BF02013993_CR34","first-page":"81","volume-title":"Ciprofloxacin: a new 4-quinolone","author":"P. Schacht","year":"1985","unstructured":"Schacht, P., Bruck, H., Chysky, V., Hullman, R., Weuta, H., Arcieri, G., Branolte, J., Konopka, C., Papachristou, C., Westwood, A.: Overall clinical results with ciprofloxacin. In: Ciprofloxacin: a new 4-quinolone. Sieber and McIntyre. Hongkong, 1985, 81\u201388."},{"key":"BF02013993_CR35","first-page":"6","volume":"1","author":"P. M. Shah","year":"1984","unstructured":"Shah, P. M.: Ciprofloxacin in the treatment of cystic fibrosis. Quinolones Bulletin 1984, 1: 6.","journal-title":"Quinolones Bulletin"},{"key":"BF02013993_CR36","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1128\/AAC.9.3.387","volume":"9","author":"J. P. Sanford","year":"1976","unstructured":"Sanford, J. P., Linh, N. N., Kutscher, E., Arnold, K., Gould, K.: Oxolinic acid in the treatment of typhoid fever due to chloramphenicol-resistant strains ofSalmonella typhi. Antimicrobial Agents and Chemotherapy 1976, 9: 387\u2013390.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02013993_CR37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/AAC.28.1.128","volume":"28","author":"C. Ramirez","year":"1985","unstructured":"Ramirez, C., Bran, J. L., Mejia, C. R., Garcia, J. F.: Open prospective study of the clinical efficacy of ciprofloxacin. Antimicrobial Agents and Chemotherapy 1985, 28: 128\u2013132.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02013993_CR38","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF02013994","volume":"5","author":"G. Arcieri","year":"1986","unstructured":"Arcieri, G., August, R., Becker, N., Doyle, C., Griffith, E., Gruenwaldt, G., Heyd, A., O'Brien, B.: Clinical experience with ciprofloxacin in the USA. European Journal of Clinical Microbiology 1986, 5: 220\u2013225.","journal-title":"European Journal of Clinical Microbiology"},{"key":"BF02013993_CR39","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/BF02013997","volume":"5","author":"F. Follath","year":"1986","unstructured":"Follath, F., Bindschelder, M., Wenk, M., Frei, R., Stalder, H., Reber, H.: Use of ciprofloxacin in the treatment ofPseudomonas aeruginosa infections. European Journal of Clinical Microbiology 1986, 5: 236\u2013240.","journal-title":"European Journal of Clinical Microbiology"},{"key":"BF02013993_CR40","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1128\/AAC.28.2.308","volume":"27","author":"L. J. Eron","year":"1985","unstructured":"Eron, L. J., Harvey, L., Hixon, D. L., Poretz, D. M.: Ciprofloxacin therapy of infections caused byPseudomonas aeruginosa and other resistant bacteria. Antimicrobial Agents and Chemotherapy 1985, 27: 308\u2013310.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02013993_CR41","first-page":"71","volume-title":"Ciprofloxacin: a new 4-quinolone","author":"S. Baba","year":"1985","unstructured":"Baba, S.: Clinical evaluation of Bay 09867 in the fields of surgery, obstetrics and gynaecology, dermatology, otorhinolaryngology and ophthalmology. In: Ciprofloxacin: a new 4-quinolone. Sieber and McIntyre. Hongkong, 1985, 71\u201379."},{"key":"BF02013993_CR42","first-page":"85","volume-title":"Ciprofloxacin: a new 4-quinolone","author":"H. Kobayashi","year":"1985","unstructured":"Kobayashi, H.: Summary of clinical studies on ciprofloxacin. In: Ciprofloxacin: a new 4-quinolone. Sieber and McIntyre. Hongkong, 1985, 85\u201388."},{"key":"BF02013993_CR43","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0140-6736(84)92617-5","volume":"ii","author":"F. P. V. Maesen","year":"1984","unstructured":"Maesen, F. P. V., Teengs, J. P., Baur, C., Davies, B. I.: Quinolones and raised plasma concentrations of theophylline. Lancet 1984, ii: 530.","journal-title":"Lancet"},{"key":"BF02013993_CR44","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0140-6736(84)90283-6","volume":"i","author":"W. J. A. Wiinands","year":"1984","unstructured":"Wiinands, W. J. A., van Heerwarden, C. L. A., Vree, T. B.: Enoxacin raises plasma theophylline concentrations. Lancet 1984, i: 108\u2013109.","journal-title":"Lancet"}],"container-title":["European Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02013993.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02013993\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02013993","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T22:25:33Z","timestamp":1557786333000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02013993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,4]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1986,4]]}},"alternative-id":["BF02013993"],"URL":"https:\/\/doi.org\/10.1007\/bf02013993","relation":{},"ISSN":["0722-2211","1435-4373"],"issn-type":[{"value":"0722-2211","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,4]]}}}